Clinical trial
Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal…
NCT00001615 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00001615 |
|---|---|
| Title | Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration |
| Official title | Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Choroidal Neovascularization, Macular Degeneration |
| Intervention type | Drug |
| Interventions | Corticosteroid |
| Enrollment | 180 |
| Start date | Jul 1, 1997 |
| Completion | May 1, 2000 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: